spacer
home > pmps > spring 2019 > a toxic conversation
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Toxic Conversation

A cleanroom is one of the biggest single investments any business is likely to make. There are many great reasons why companies literally cannot afford to get it wrong, so it makes sense to ensure it is kept operational for as long as possible. The fact of the matter is that overspecifying on sterilisation could well be increasing the lifetime cost of cleanrooms through the wholly avoidable degradation of furniture and equipment.

All fixtures and fittings in cleanrooms must facilitate Good Manufacturing Practice, meaning that materials from which they are constructed need to be chemically inert. It should also be tough enough to withstand the regular sterilisation, which is why austenitic stainless steel has always been such a common feature in cleanroom design. Furniture and other equipment built from this material will maintain its structural integrity for decades, not years. However, this is only the case when it is looked after properly, which means matching it to the chosen sterilisation option and also ensuring it is not at risk from detergents and disinfectants.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Sue Springett is Commercial Manager at Teknomek, which produces hygienic furniture and equipment. Having previously held similar positions in manufacturing and service industries, she has helped Teknomek introduce a series of new products specifically for cleanroom users.
spacer
Sue Springett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals enters into manufacturing agreement with the Swedish company Affibody

[Noáin, May 27, 2019] 3P Biopharmaceuticals, a leading CDMO specialized in the process development and GMP manufacturing of biologics, has signed a collaboration agreement with the Swedish company Affibody for the process transfer, scale-up and GMP commercial manufacturing of a recombinant protein sole property of Affibody.
More info >>

White Papers
 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement